Development of standard clinical endpoints for use in dengue interventional trials
Dengue is a major public health problem worldwide. Although several drug candidates have been evaluated in randomized controlled trials, none has been effective and at present, early recognition of severe dengue and timely supportive care are used to reduce mortality. While the first dengue vaccine...
Hlavní autoři: | Tomashek, K, Wills, B, See Lum, L, Thomas, L, Durbin, A, Leo, Y, De Bosch, N, Rojas, E, Hendrickx, K, Erpicum, M, Agulto, L, Jaenisch, T, Tissera, H, Suntarattiwong, P, Collers, B, Wallace, D, Schmidt, A, Precioso, A, Narvaez, F, Thomas, S, Edelman, R, Siqueira, J, Cassetti, M, Dempsey, W, Gubler, D |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Public Library of Science
2018
|
Podobné jednotky
-
Development of standard clinical endpoints for use in dengue interventional trials
Autor: Tomashek, Kay M., a další
Vydáno: (2018) -
Severe dengue categories as research endpoints—results from a prospective observational study in hospitalised dengue patients
Autor: Rosenberger, KD, a další
Vydáno: (2020) -
Dogma in classifying dengue disease.
Autor: Farrar, J, a další
Vydáno: (2013) -
Dogma in classifying dengue disease
Autor: Farrar, J, a další
Vydáno: (2013) -
Helicopter EMS: Research Endpoints and Potential Benefits
Autor: Stephen H. Thomas, a další
Vydáno: (2012-01-01)